Hepatitis C in dialysis units: The Saudi experience

Hemodialysis International

Volumn 11, Issue 3, 2007, Pages 354-367

  Karkar, Ayman ^a  

^a DAMMAM CENTRAL HOSPITAL   (Saudi Arabia)

Author keywords

Hemodialysis; Hepatitis C; Infection control; Isolation; Prevention

Indexed keywords

ALPHA INTERFERON; PEGINTERFERON ALPHA2A; RIBAVIRIN;

ARTICLE; ARTIFICIAL KIDNEY; CELLULAR IMMUNODEFICIENCY; CHRONIC HEPATITIS; CLINICAL TRIAL; COLITIS; COMBINATION CHEMOTHERAPY; CONTINUOUS INFUSION; DEVELOPING COUNTRY; DISEASE SEVERITY; EXPERIENCE; GENOTYPE; HEALTH CARE POLICY; HEALTH SERVICE; HEMODIALYSIS; HEPATITIS C; HEPATITIS C VIRUS; HIGH RISK POPULATION; HUMAN; INFECTION CONTROL; INFECTION PREVENTION; INFECTION RISK; KIDNEY FAILURE; LIVER CARCINOMA; LIVER CIRRHOSIS; LIVER HISTOLOGY; MIXED INFECTION; MONOTHERAPY; PATIENT CARE; PATIENT COMPLIANCE; PATIENT EDUCATION; PREVALENCE; SAUDI ARABIA; SEROCONVERSION; STAFF TRAINING; UNSPECIFIED SIDE EFFECT; VIRUS INFECTION; VIRUS TRANSMISSION; WESTERN HEMISPHERE;

ANTIVIRAL AGENTS; EDUCATION, NURSING, CONTINUING; GENOTYPE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; INFECTION CONTROL; INTERFERON-ALPHA; KIDNEY FAILURE, CHRONIC; PREVALENCE; RENAL DIALYSIS; RIBAVIRIN; SAUDI ARABIA;

EID: 34250753740     PISSN: 14927535     EISSN: 15424758     Source Type: Journal    
DOI: 10.1111/j.1542-4758.2007.00192.x     Document Type: Article

References (73)

1. Pereira BJ, Milford EL, Kirkman RL, Levey AS. Transmission of hepatitis C virus by organ transplantation. N Engl J Med. 1991; 325: 454-460.
2. Fishman JA, Rubin RH, Koziel MJ, Pereira BJ. Hepatitis C virus and organ transplantation. Transplantation. 1996; 62: 147-154.
3. Natov SN. Transmission of viral hepatitis by kidney transplantation: Donor evaluation and transplant policies (Part 2: Hepatitis C virus). Transplant Infect Dis. 2002; 4: 124-131.
4. Al-Quaiz MN, Madani TA, Karawi MA. The natural history of hepatitis C virus infection. Saudi Med J. 2003; 2 (Suppl 24): S67-S70.
5. Tokars JI, Miller ER, Alter MJ, et al. National surveillance of dialysis associated disease in the United States. ASAIO J. 1998; 44: 98-107.
6. Quiroga JA, Llorente S, Castillo I, Rodriguez-Inigo E, Pardo M, Carreno V. Cellular immune responses associated with occult hepatitis C virus infection of the liver. J Virol. 2006; 80: 10972-10979.
7. Saxena AK, Panhotra BR. The prevalence of nasal carriage of Staphylococcus aureus and associated vascular access-related septicemia among patients on hemodialysis in Al-Hasa Region of Saudi Arabia. Saudi J Kidney Dis Transplant. 2003; 14: 30-38.
8. Kishi Y, Sugawara Y, Tamura S, Kaneko J, Matsui Y, Makuuchi M. New-onset diabetes mellitus after living donor liver transplantation: Possible association with hepatitis C. Transplant Proc. 2006; 38: 2989-2992.
9. Martin P, Carter D, Fabrizi F, et al. Histopathological features of hepatitis C in renal transplant candidates. Transplantation. 2000; 69: 1479-1484.
10. Sterling PK, Sanyal AJ, Luketic VA, et al. Chronic hepatitis C infection in patients with end-stage renal disease: Characterization of liver histology and viral load in patients awaiting renal transplantation. Am J Gastroenterol. 1999; 94: 3576-3582.
11. Huraib S, Al-Rashed R, Aldrees A, Aljefry M, Arif M, Al-Faleh FA. High prevalence of and risk factors for hepatitis C in hemodialysis patients in Saudi Arabia: A need for new dialysis strategies. Nephrol Dial Transplant. 1995; 10: 470-474.
12. Huraib SO. Hepatitis C in dialysis patients. Saudi J Kidney Dis Transplant. 2003; 14: 442-450.
13. Al-Jiffri AMY, Fadeg RB, Ghabrah TM, Ibrahim A. Hepatitis C virus infection among patients on hemodialysis in Jeddah: A single center experience. Saudi J Kidney Dis Transplant. 2003; 14: 84-89.
14. Goldberg D, Anderson E. Hepatitis C: Who is at risk and how do we identify them? J Viral Hepatitis. 2004; 11 (Suppl 1): 12-18.
15. Ayoola EA, Gadour MO. Hepatocellular carcinoma in Saudi Arabia: Role of hepatitis B and C infection. J Gastroenterol Hepatol. 2004; 19: 665-669.
16. Aldrees A, Paul TT, Abu-Aisha H, Babiker MA, Kurpad R, Aswad S. Cost evaluation of hemodialysis in ministry of health hospitals, Saudi Arabia: A NKF study. Saudi Kidney Dis Transplant Bull. 1991; 2: 125-133.
17. Saudi Center for Organ Transplantation Annual Report, 2006. http://www.scot.org.sa
18. Delic D, Nesic Z, Simonovic J, Svirtlih N, Dokic L, Neskovic G. Chronic hepatitis C virus infection: Is there a correlation between HCV genotypes and the level of viremia? Med Pregl. 2006; 59: 230-234.
19. Lau JY, Davis GL, Prescott LE, et al. Distribution of hepatitis C virus genotypes determined by line probe assay in patients with chronic hepatitis C seen at tertiary referral centers in the United States. Hepatitis Interventional Therapy Group. Ann Intern Med. 1996; 124: 868-876.
20. Al-Faleh FZ, Huraib S, Sbeih F, et al. Hepatitis C virus genotypes in patients with chronic liver disease and hemodialysis patients from Saudi Arabia. J Viral Hepatitis. 1995; 2: 293-296.
21. Bosmans JL, Nouwen EJ, Behets G, et al. Prevalence and clinical expression of HCV-genotypes in hemodialysis-patients of two geographically remote countries: Belgium and Saudi Arabia. Clin Nephrol. 1997; 47: 256-262.
22. Shobokshi OA, Serebour FE, Skakni L, Al-Saffy YH, Ahdal MN. Hepatitis C genotypes and subtypes in Saudi Arabia. J Med Virol. 1999; 58: 44-48.
23. Fakeeh M, Zaki AM. Hepatitis C: Prevalence and common genotypes among ethnic groups in Jeddah, Saudi Arabia. Am J Trop Med Hyg. 1999; 61: 889-892.
24. Al-Knawy B, Okamoto H, Ahmed El-Mekki A, et al. Distribution of hepatitis C genotype and coinfection rate with hepatitis G in Saudi Arabia. Hepatol Res. 2002; 24: 95-98.
25. Shobokshi OA, Serebour FE, Skakni LI. Hepatitis C genotypes/subtypes among chronic hepatitis patients in Saudi Arabia. Saudi Med J. 2003; 2 (Suppl 24): S87-S91.
26. Al-Traif I, Handoo FA, Al-Jumah A, Al-Nasser M. Chronic hepatitis C: Genotypes and response to anti-viral therapy among Saudi patients. Saudi Med J. 2004; 25: 1935-1938.
27. Bergman S, Accortt N, Turner A, Glaze J. Hepatitis C infection is acquired pre-ESRD. Am J Kidney Dis. 2005; 45: 684-689.
28. Zampieron A, Jayasekera H, Elseviers M, et al. European study on epidemiology and management of hepatitis C virus (HCV) infection in the hemodialysis population. Part 3: Prevalence and incidence. EDTA-ERA J. 2006; 32: 42-44.
29. Izopet J, Sandres-Saune K, Kamar N, et al. Incidence of HCV infection in French hemodialysis units: A prospective study. J Med Virol. 2005; 77: 70-76.
30. Di Napoli A, Pezzotti P, Di Lallo D, Petrosillo N, Trivelloni C, Di Giulio S. Lazio dialysis registry. Epidemiology of hepatitis C virus among long-term dialysis patients: A 9-year study in an Italian region. Am J Kidney Dis. 2006; 48: 629-637.
31. Silva LK, Silva MB, Rodart IF, et al. Prevalence of hepatitis C virus (HCV) infection and HCV genotypes of hemodialysis patients in Salvador, Northeastern Brazil. Braz J Med Biol Res. 2006; 39: 595-602.
32. Ayoola EA, Huraib S, Arif M, et al. Prevalence and significance of antibodies to hepatitis C virus among Saudi hemodialysis patients. J Med Virol. 1991; 35: 155-159.
33. Hussein MM, Mooij JM, Roujouleh H, El-Sayed H. Observations in a Saudi-Arabian dialysis population over a 13-year period. Nephrol Dial Transplant. 1994; 9: 1072-1076.
34. Ahmad MS, Mahtab AM, Al Shaibi A, Amin Tashkandy M, Kashreed MSD, Maulana A. Prevalence of antibodies against the hepatitis C virus among voluntary blood donors at a Makkah hospital, Saudi Arabia. Saudi J Kidney Dis Transplant. 1995; 6: 122-124.
35. Al-Muhanna FA. Hepatitis C virus infection among hemodialysis patients in the eastern region of Saudi Arabia. Saudi J Kidney Dis Transplant. 1995; 6: 125-127.
36. Al Shohaib SS, Abdelaal MA, Zawawi TH, Abbas FM, Shaheen FAM, Amoah E. The prevalence of hepatitis C virus antibodies among hemodialysis patients in Jeddah area, Saudi Arabia. Saudi J Kidney Dis Transplant. 1995; 6: 128-131.
37. Bernieh B, Allam M, Halepota A, Mohamed AO, Parkar J, Tabbakh A. Prevalence of hepatitis C virus antibodies in hemodialysis patients in Madinah Al Munawarah. Saudi J Kidney Dis Transplant. 1995; 6: 132-135.
38. Shaheen FAM, Huraib SO, Al-Rashed R, et al. Prevalence of hepatitis C antibodies among hemodialysis patients in the Western Province of Saudi Arabia. Saudi J Kidney Dis Transplant. 1995; 6: 136-139.
39. Omer MN, Tashkandy MA, El Tonsy AH. Liver enzymes and protein electrophoretic patterns in hemodialysis patients with antibodies against the hepatitis C virus. Saudi J Kidney Dis Transplant. 1995; 6: 163-166.
40. Souqiyyeh MZ, Shaheen FAM, Huraib SO, Al-Khader AA. The annual incidence of seroconversion of antibodies to the hepatitis C virus in the hemodialysis population in Saudi Arabia. Saudi J Kidney Dis Transplant. 1995; 6: 167-173.
41. Soyannwo MA, Khan N, Kommajosyula S, et al. Hepatitis C antibodies in hemodialysis and pattern of end-stage renal failure in Gassim, Saudi Arabia. Afr J Med Med Sci. 1996; 25: 13-22.
42. Al-Mugeiren M, Al-Rasheed S, Al-Salloum A, et al. Successful therapy of tuberculosis in hemodialysis patients. Am J Nephrol. 1997; 17: 32-35.
43. Kumar R. Hepatitis C virus infection among hemodialysis patients in the Najran Region of Saudi Arabia. Saudi J Kidney Dis Transplant. 1997; 8: 134-137.
44. Souqiyyeh MZ, Al-Attar MB, Zakaria H, Shaheen FAM. Dialysis centers in the Kingdom of Saudi Arabia. Saudi J Kidney Dis Transplant. 2001; 12: 293-304.
45. Saxena AK, Panhotra BR, Sundaram DS, et al. Impact of dedicated space, dialysis equipment, and nursing staff on the transmission of hepatitis C virus in a hemodialysis unit of the Middle East. Am J Infect Control. 2003; 31: 26-33.
46. Kashem A, Nusairat I, Mohamad M, et al. Hepatitis C virus among hemodialysis patients in Najran: Prevalence is more among multi-center visitors. Saudi J Kidney Dis Transplant. 2003; 14: 206-211.
47. Shobokshi OA, Tantawe AO, Al-Kayyal BM. Chronic hepatitis C treatment, side effects and their management. Saudi Med J. 2003; 2 (Suppl 24): S76-S78.
48. Almawi WY, Qadi AA, Tamim H, et al. Seroprevalence of hepatitis C virus and hepatitis B virus among dialysis patients in Bahrain and Saudi Arabia. Transplant Proc. 2004; 36: 1824-1826.
49. Karkar A, Abdulrahman MR, Ghacha R, Tahir QM. Prevention of viral hepatitis in hemodialysis units: The value of isolation. Saudi J Kidney Dis Transplant. 2006; 17: 183-188.
50. Al-Faleh FZ. Changing pattern of hepatitis viral infection in Saudi Arabia in the last two decades. Ann Saudi Med. 2003; 23: 367-371.
51. El-Hazmi MM. Prevalence of HBV, HCV, HIV-1, 2 and HTLV-I/II infections among blood donors in a teaching hospital in the Central region of Saudi Arabia. Saudi Med J. 2004; 25: 26-33.
52. Bamaga MS, Bokhari FF, Aboud AM, Al-Malki M, Alenzi FQ. Nucleic acid amplification technology screening for hepatitis C virus and human immunodeficiency virus for blood donations. Saudi Med J. 2006; 27: 781-787.
53. Memish Z, Qasim L, Abed E, et al. Pattern of viral hepatitis infection in a selected population from Saudi Arabia. Mil Med. 2003; 168: 565-568.
54. Saxena AK, Panhotra BR. The vulnerability of middle-aged and elderly patients to hepatitis C virus infection in a high-prevalence hospital-based hemodialysis setting. J Am Geriatr Soc. 2004; 52: 242-246.
55. Abu-Aisha H, Mitwalli A, Huraib SO, et al. The effect of chemical and heat disinfection of the hemodialysis machines on the spread of hepatitis C virus infection: A prospective study. Saudi J Kidney Dis Transplant. 1995; 6: 174-178.
56. Al-Ghamdi SMG, Al-Harbi AS. Hepatitis C virus sero-status in hemodialysis patients returning from holiday: Another risk factor for HCV transmission. Saudi J Kidney Dis Transplant. 2001; 12: 14-20.
57. Saxena AK, Panhotra BR. The impact of nurse understaffing on the transmission of hepatitis C virus in a hospital-based hemodialysis unit. Med Princ Pract. 2004; 13: 129-135.
58. Al-Ghamdi SMG. Nurses' knowledge and practice in hemodialysis units: Comparison between nurses in units with high and low prevalence of hepatitis C virus infection. Saudi J Kidney Dis Transplant. 2004; 15: 34-40.
59. Gallego E, Lopez A, Perez J, et al. Effect of isolation measures on the incidence and prevalence of hepatitis C virus infection in hemodialysis. Nephron Clin Pract. 2006; 104: C1-C6.
60. Al-Faleh FZ, Sbeih F, Al-Karawi M, et al. Treatment of chronic hepatitis C genotype 4 with alpha-interferon in Saudi Arabia: A multicenter study. Hepatogastroenterology. 1998; 45: 488-491.
61. Al-Faleh FZ, Aljumah A, Rezeig M, et al. Treatment of chronic hepatitis C genotype IV with interferon-ribavirin combination in Saudi Arabia: A multicentre study. J Viral Hepatitis. 2000; 7: 287-291.
62. Akbar HO. Treatment of patients with chronic hepatitis C with normal liver enzymes. Saudi Med J. 2002; 23: 301-304.
63. Akbar HO. Effect of induction therapy on hepatitis C. Saudi Med J. 2002; 23: 773-776.
64. Al-Faleh FZ, Hadad Q, Khuroo MS, et al. Peginterferon alpha-2b plus ribavirin compared with interferon alpha-2b plus ribavirin for initial treatment of chronic hepatitis C in Saudi patients commonly infected with genotype 4. Liver Int. 2004; 24: 568-574.
65. Al-Harbi ASB, Malik GH, Subaity Y, Mansy H, Abutaleb N. Treatment of acute hepatitis C virus infection with alpha interferon in patients on hemodialysis. Saudi J Kidney Dis Transplant. 2005; 16: 293-297.
66. Bruchfeld A, Stahle L, Andersson J, Schvarcz R. Ribavirin treatment in dialysis patients with chronic hepatitis C infection: A pilot study. J Viral Hepatitis. 2001; 8: 287-292.
67. Bruchfeld A, Lindahl K, Stahle L, Soderberg M, Schvarcz R. Interferon and ribavirin treatment in patients with hepatitis C-associated renal disease and renal insufficiency. Nephrol Dial Transplant. 2003; 18: 1573-1580.
68. Arambarri M, Fernandez Lucas M, Echarri R, et al. Therapy with interferon plus ribavirin in hemodialysis patients with PCR-positive viral hepatitis C. Nephrologia. 2004; 3 (Suppl 24): 39-42.
69. Mousa DH, Abdalla AH, Al-Shoail G, Al-Sulaiman MH, Al-Hawas FA, Al-Khader AA. Alpha-interferon with ribavirin in the treatment of hemodialysis patients with hepatitis C. Tranplant Proc. 2004; 36: 1831-1834.
70. Russo MW, Ghalib R, Sigal S, Joshi V. Randomized trial of pegylated interferon α-2b monotherapy in hemodialysis patients with chronic hepatitis C. Nephrol Dial Transplant. 2006; 21: 437-443.
71. Bruchfeld A, Lindahl K, Reichard O, Carlsson T, Schvarcz R. Pegylated interferon and ribavirin in hemodialysis patients. Nephrol Dial Transplant. 2006; 21: 1444-1445.
72. Potthoff A, Wiegand J, Luth JB, Wedemeyer H, Manns MP, Tillmann HL. Superiority of standard interferon-alpha 2b compared to pegylated interferon-alpha 2b (12 kDa) in a hemodialysis patients with chronic hepatitis C. Clin Nephrol. 2005; 63: 232-235.
73. Alfureyh O, Al-Ghamdi S, Al-Harbi A, et al. Guidelines for renal transplantation in Saudi Arabia. Saudi Center Organ Transplantation. http://www.scot.org.sa. 2006.